If you have been reading about Heptapeptide and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.
Last reviewed on 2026-07-04. Where a claim depends on a specific study, the study is described rather than over-claimed.
Semax is a synthetic heptapeptide with the sequence Met-Glu-His-Phe-Pro-Gly-Pro. It is described in the literature as an analogue of the ACTH(4–10) fragment, a short N-terminal portion of adrenocorticotropic hormone that retains some neurotropic activity without the full hormonal effects of the parent peptide. The molecule carries a methionine residue at the N-terminus and two proline residues near the C-terminus, features that shape both its interactions with receptor systems and its chemical stability. The free peptide corresponds to the formula C37H51N9O10S and a molecular mass near 813.9 Da.
The compound was developed in the 1980s at the Institute of Molecular Genetics in Moscow, where it emerged from research on short ACTH fragments and their effects on the central nervous system. Russian pharmaceutical listings describe it as a nootropic and neuroprotective agent, most often formulated as nasal drops. It is not a marketed medicine in the United States or the European Union, and no pharmacopoeial monograph covers it. Consequently, most published clinical experience with the substance originates from a small number of research centres, mainly in Russia and neighbouring countries.
Pharmacological accounts link semax to melanocortin signalling and to modulation of neurotrophic factor expression, particularly brain-derived neurotrophic factor and nerve growth factor. Much of this evidence comes from rodent studies using intranasal delivery, a route chosen because it allows peptides to reach the central nervous system with limited systemic exposure. Whether the same mechanisms operate in humans at comparable magnitude remains an open question. The precise receptor or receptors responsible for the reported behavioural and neuroprotective effects have not been conclusively identified.
Semax is a synthetic heptapeptide whose sequence is Met-Glu-His-Phe-Pro-Gly-Pro. The first four residues correspond to the ACTH(4-10) fragment, while the terminal Pro-Gly-Pro extension was added to improve metabolic stability. Its molecular formula is C37H51N9O10S and its monoisotopic mass is approximately 813.9 Da. The compound is classified as a peptide research chemical and as a registered pharmaceutical product in Russia, but it does not hold marketing approval in the European Union or the United States. Naming conventions vary across supplier catalogs.
Development of the compound took place in the Soviet Union during the 1980s, largely through peptide research groups affiliated with the Shemyakin-Ovchinnikov Institute and Moscow State University. Investigators screened fragments of adrenocorticotropic hormone for activity on the central nervous system while attempting to separate cognitive effects from hormonal ones. The shortened sequence was selected because it retained behavioral activity in animal models without stimulating corticosteroid release. Early publications described the molecule as an ACTH(4-10) analog.
| Property | Value | Notes |
|---|---|---|
| Molecular formula | C37H51N9O10S | Free acid form of the heptapeptide; depends on terminal groups |
| Molecular mass | About 813.9 g/mol | Average mass used for mass spectrometry confirmation |
| Appearance | White to off-white solid | Supplied as a lyophilised powder; hygroscopic |
| Solubility class | Freely soluble in aqueous media | Water, saline, and phosphate buffers; limited organic solubility |
| Typical storage temperature | -20 degrees Celsius | Long term and dry; short working periods may use 2 to 8 degrees Celsius |
Semax is a synthetic heptapeptide with the sequence Met-Glu-His-Phe-Pro-Gly-Pro. It was derived from the ACTH(4-10) fragment, a short segment of adrenocorticotropic hormone that lacks the hormonal activity associated with the full-length peptide. Researchers at the Institute of Molecular Genetics in Moscow developed the compound during the 1980s. It has been registered as a pharmaceutical product in Russia and several neighbouring countries, where it is supplied as a nasal solution, and it is also sold internationally as a research chemical.
The proposed mechanism centres on neurotrophic signalling rather than direct receptor activation. Semax is reported to increase expression of brain-derived neurotrophic factor and nerve growth factor in several brain regions, and to shift the balance between excitatory and inhibitory neurotransmitter systems. Interaction with melanocortin receptors has been suggested because of the parent ACTH fragment. Many of these findings come from rodent studies, and the extent to which they translate to human physiology remains an open question.
== Risks == There are over 250 toxins and carcinogens in cigarette smoke. The risks of developing lung cancer, brain tumors, and acute myeloid leukemia and the incidence of heart disease and benign respiratory diseases increase with the inhalation of sidestream smoke. Additionally, the chance of developing breast cancer and cervical cancer also increases with the inhalation of sidestream smoke. Evidence has shown that sidestream smoke may be more harmful, per gram, than mainstream smoke. However, sidesmoke is inhaled in far lesser amounts than mainstream smoke in people who smoke tobacco. The relative risk of cardiovascular disease is 1.2–1.3 with exposure to sidestream smoke due to the cyanide present in the smoke. There is also evidence that sidestream smoke causes negative effects in children, both behaviorally and cognitively. One study found that higher levels of cotinine in children were correlated with a decreased ability to perform in reading and math. Factors such as age, gender and different occupations put a person at risk for bladder cancer - smoking is the only other known risk. 4-aminobiphenyl (4-ABP) is an integral component in tobacco smoke, as well as a risk factor for bladder cancer. Sidestream smoke puts individuals at an increased risk of bladder cancer because the 4-ABP concentrations are over ten times that of mainstream smoke.
=== China === Castillo has sought to improve relations with China. The Castillo Administration sees China as an essential trade partner, and as a partner for vaccine procurement. China is the main buyer of Peru's copper, a crucial source of the country's tax revenue. In the first week of Castillo's government, cabinet members met with Liang Yu, China's ambassador to Peru, and executives from major mining companies from the Asian country, following campaign announcements in which Castillo announced higher mining taxes and the review of tax stability agreements signed with transnational corporations, which caused concern among Chinese companies. Following a meeting between Yu and Roberto Sánchez, minister of foreign trade and tourism, it was announced that, virtually, technical teams from Peru and China were working on the "optimization of the FTA between both countries". Subsequently, in February 2022, lobbyist Karelim López testified before prosecutors about the existence of an alleged mafia within the Ministry of Transport and Communications (MTC) that was led by Castillo and Juan Silva, minister of the MTC, and included the congressmen known as "Los Niños" in order to steer public works in exchange for favors.
Furthermore, a deficiency in GIP receptors has been associated in mice with a dramatic decrease in bone quality and a subsequent increase in fracture risk. However, the results of the two groups' studies were non-concordant.
Sources: en.wikipedia.org
Isobutyryl-CoA + 6 malonyl-CoA +12 NADPH + 12H+ → Isopalmitic acid + 6 CO2 12 NADP + 5 H2O + 7 CoA The difference between (straight-chain) fatty acid synthase and branch-chain fatty acid synthase is substrate specificity of the enzyme that catalyzes the reaction of acyl-CoA to acyl-ACP.
=== Protein === C3orf52 consists of a disordered region, a transmembrane region, and a major polyA site. The molecular weight is of 24.3 kDa. This protein is predicted to be localized primarily in the cytoplasm (94.1%), with specific localization to the endoplasmic reticulum (44.4%). The protein is associated with two distinct isoforms; isoform 1 is 250 amino acids long, while isoform 2 is 217 amino acids long. In human research, isoform 2 is the predominant variation found and is the most common focus for research on C3orf52. Compositional analysis has indicated that this protein is acidic in nature, with a predicted isoelectric point of 3.99. Additionally, results show a high-scoring transmembrane segment spanning amino acids 66 to 93, which is also among the protein's most hydrophobic segment. C3orf52 contains a repetitive four-amino acid motif, including a sequence reading "LELS" at amino acids 13-16 and repeating at positions 101–104, this region is not conserved among orthologs.
== Notable people == Túpac Amaru II, revolutionary Angélica Mendoza de Ascarza, Peruvian human rights activist Kimberly Barzola, American community organizer and artist Benjamin Bratt, American actor Manco Cápac, Sapa Inca Luzmila Carpio, Bolivian musician Andrónico Rodríguez, Bolivian trade unionist and politician Martín Chambi, Peruvian photographer Renata Flores Rivera, Peruvian musician Oswaldo Guayasamín, Ecuadorian painter Ollanta Humala, former president of Peru Antauro Humala, Peruvian ethnocacerist Josh Keaton, American actor Q'orianka Kilcher, American actress Nancy Iza Moreno, Kichwa leader Leonidas Iza, Ecuadorian activist and Indigenous leader Delfín Quishpe, Ecuadorian musician and politician Tarcila Rivera Zea, Peruvian activist Izkia Siches, Chilean physician and politician Magaly Solier, Peruvian actress and musician Diego Quispe Tito, painter Francisco Tito Yupanqui, sculptor Alejandro Toledo, former president of Peru Edison Flores, Peruvian footballer Renato Tapia, Peruvian footballer Tania Pariona Tarqui, Peruvian politician
Sources: en.wikipedia.org
In the second phase of the program, the Nigerian government developed the Nigerian Agricultural Payment Initiative (NAPI), which distributed PIN-enabled ID cards that hold subsidy information and provide access to loans and grants. Other e-wallet/e-voucher systems for agricultural subsidies exist or have been piloted in Colombia, Rwanda, Zambia, Mali, Guinea, and Niger. Besides reducing subsidy costs, governments can harness digital technology to save time. When Estonia implemented their e-ID and X-Road system, time spent applying for agricultural subsidies decreased from 300 minutes to 45 minutes per person. Typically, a system of digital agriculture technologies, rather than a single tool, is used to solve multifaceted problems. For example, e-commerce solves two efficiency issues: difficulty matching buyers and sellers, especially in rural areas, and the high transaction costs associated with in-person, cash-based trade.
== SQ == sq – (s) Albanian language (ISO 639-1 code) SQ – (i) Sound Quality SQ – (i) Standard Quality sqi – (s) Albanian language (ISO 639-2 code) SQL – (i/a) Structured Query Language ("seek-well") SQS - Amazon Simple Queue Service SQUID – (p) Superconducting QUantum Interference Device SQOR – (p) Succinate:Quinone OxidoReductase, enzyme superfamily including quinone-linked succinate dehydrogenase and fumarate reductase
=== Blood deserts === Since blood products acquisition, storage, transportation, and administration requires extensive infrastructure, there are several regions in which there is no blood, colloquially referred to as blood deserts. In these regions, blood transfusion is often not possible, and communities may have to rely on the commonly illegal practice of drawing blood directly from other community members. Blood deserts are a serious global health crisis that affects many people every year.
Sources: en.wikipedia.org
It is described as a synthetic analogue of the ACTH(4–10) fragment, a short segment of adrenocorticotropic hormone. Its sequence differs from that fragment and includes two proline residues, which influence stability and behaviour in solution.
It appears in Russian pharmaceutical listings as a nasal formulation, but it is not an authorised medicine in the United States or the European Union. Outside those markets it is normally encountered as a research chemical rather than a prescription product.
Laboratory and animal work points to melanocortin signalling and changes in neurotrophic factor levels, especially brain-derived neurotrophic factor. The exact receptor targets and the degree to which these findings transfer to humans are still unresolved.
It is a synthetic peptide of seven amino acids. Its backbone corresponds to a fragment of adrenocorticotropic hormone extended at the carboxyl end. The material is distributed as a lyophilized solid for laboratory use.